Neimeth International Pharmaceuticals Plc announced earnings results for the first quarter ended December 31, 2019. For the first quarter, the company announced sales was NGN 606.475 million compared to NGN 227.068 million a year ago. Operating income was NGN 111.678 million compared to operating loss of NGN 119.301 million a year ago. Net income was NGN 82.652 million compared to net loss of NGN 139.161 million a year ago. Basic earnings per share was NGN 0.0435 compared to basic loss per share of NGN 0.08 a year ago.